Azathioprine Side Effects in Patients with Ocular Manifestations of Behçet’s Syndrome

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 26

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_CJM-3-2_001

تاریخ نمایه سازی: 30 اردیبهشت 1403

چکیده مقاله:

Introduction: Behçet’s syndrome (BS) is a systemic vasculitis characterized by skin involvement, uveitis, and arthritis. Azathioprine is an effective therapy among other immunosuppressive drugs for this disease but there is no clear data about all aspects of its side effects in BS patients with ocular manifestations. we want to determine the prevalence and types of adverse effects related with azathioprine in ocular BS patients. Methods: the study is  cross-sectional with ۱۶۵ confirmed diagnosis of BS patients who had ocular involvement. Data were collected retrospectively with medical records of the BS clinic. Results: Of ۱۶۵ enrolled patients, Adverse events of treatment with azathioprine occurred in ۱۱ patients (۶.۶۷%). side effects included: elevated of liver enzymes in four patients (۲.۴۳%), hypersensitive reaction in ۲ patients (۱.۲۱%), leukopenia in ۲ patients (۱.۲۱%), nausea in ۱ patient (۰.۶۱%), skin tumor in ۱ patient (۰.۶۱%), and t pancreatitis and hepatitis in one patient (۰.۶۱). Conclusion: azathioprine reduced the rate of adverse effects and resolution of the ocular manifestations in patients with BS and has few side effects so, it is good choice to treat patients with BS.

نویسندگان

- -

Clinical Research Development Center, Shahid Beheshti Hospital, Qom University of Medical Sciences, Azadegan Sq., Shahid Beheshti Blvd, Qom, Iran

- -

Student Research Committee, School of Medicine, Qom University of Medical Sciences, Qom, Iran

- -

Bechet&#۰۳۹;s Disease Unit, Rheumatology Research Center, Tehran University of Medical Sciences. Shariati Hospital, Tehran, Iran

- -

Bechet&#۰۳۹;s Disease Unit, Rheumatology Research Center, Tehran University of Medical Sciences. Shariati Hospital, Tehran, Iran

- -

Bechet&#۰۳۹;s Disease Unit, Rheumatology Research Center, Tehran University of Medical Sciences. Shariati Hospital, Tehran, Iran

- -

Bechet's Disease Unit, Rheumatology Research Center, Tehran University of Medical Sciences. Shariati Hospital, Tehran, Iran

- -

Bechet's Disease Unit, Rheumatology Research Center, Tehran University of Medical Sciences. Shariati Hospital, Tehran, Iran

- -

Bechet's Disease Unit, Rheumatology Research Center, Tehran University of Medical Sciences. Shariati Hospital, Tehran, Iran

- -

Bechet&#۰۳۹;s Disease Unit, Rheumatology Research Center, Tehran University of Medical Sciences. Shariati Hospital, Tehran, Iran

- -

Tehran University of Medical Sciences, Tehran, Iran

- -

Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

- -

Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

- -

Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. ...
  • Soraya S, Maryam M, Fereydoun D, Massoomeh A, Hoda K, ...
  • Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford M, ...
  • Korelitz BI. Steroids may prevent leukopenia, hastening response to IV ...
  • Benezra D, Nussenblatt R. Ocular manifestations of Behçet’s disease. Journal ...
  • Alibaz-Oner F, Direskeneli H. Advances in the Treatment of Behcet’s ...
  • Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other ...
  • Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, ...
  • Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow ...
  • Dean L. Azathioprine Therapy and TPMT and NUDT۱۵ Genotype. In: ...
  • Saadoun D, Wechsler B, Terrada C, Hajage D, Le Thi ...
  • Zhao M, Wang H, Jiao X, Wei WB. [Clinical observation ...
  • Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, ...
  • Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, ...
  • de Jong DJ, Goullet M, Naber TH. Side effects of ...
  • Smith JL, Wilkinson AH, Hunsicker LG, Tobacman J, Kapelanski DP, ...
  • Asten P, Barrett J, Symmons D. Risk of developing certain ...
  • Hricik DE, Mayes JT, Schulak JA. Independent effects of cyclosporine ...
  • Lewis JD, Schwartz JS, Lichtenstein GR. Azathioprine for maintenance of ...
  • O’Connor A, Qasim A, O’Moráin CA. The long-term risk of ...
  • Saway PA, Heck LW, Bonner JR, Kirklin JK. Azathioprine hypersensitivity. ...
  • KNOWLES SR, GUTPTA AK, SHEAR NH, SAUDER D. Azathioprine hypersensitivity-like ...
  • Jeurissen ME, Boerbooms AM, van de Putte LB, Kruijsen MW. ...
  • نمایش کامل مراجع